Research articlePublished 30 Apr 2022
Effectiveness and Predictor Response of Biological Therapy in Rheumatoid Arthritis in Libya
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Aim: Our study was to estimate effectiveness of biological therapy in Rheumatoid arthritis by using predictor response of function score, disease activity, and Pain score. Patient and method: Follow up study patients were diagnosed as rheumatoid arthritis (RA). Those patients were studied clinically and functional disability assessed by the Health Assessment Questionnaire (HAQ score) and the Disease Activity Score in 28 joints (DAS 28). Result: Ninety three patients with diagnosed rheumatoid arthritis were included in the study. Patients clinical characteristics are the age of the study patients ranged from (24-68years), M=(48 ± 13 year), 80 (86%) were female. The Mean DAS 28 activity at baseline was (4.4 ± 1.2), the mean health assessment questionnaire score (HAQ) of patients (1.2). The management of rheumatoid arthritis be combined methotrexate with biological therapy was 40 (43%) of patient on Infliximab, 24 (25.8%) of patient on Adalimumab, 19 (20.4%) of patient on Etarnercept and 10 (10.7%) of patient on Rituximab at follow-up. Mean DAS 28 activity at 6 months in patients was 1.2-3.6 M=(2.3 ± 0.5), and Mean DAS 28 activity at 12 months in patients was 0.6-2.6 M=(1.2 ± 0.4) with significant Pvalue=0.000. Clinical improvement after biological therapy at 6 and 12 months measure by American College of Rheumatology (ACR) and improvement or EULAR Response with significant Pvalue=0.000, in addition greater improvement in health assessment questionnaire score (HAQ) after biological therapy from baseline with significant Pvalue=0.000 and improvement in pain score. Conclusion: The biologics therapy had effective decline disease activity in rheumatoid arthritis, improves function score and pain score and had significant benefits in outcomes for patients.
Subjects
RheumatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Clinical Rheumatology
- SubjectRheumatology
- BylineArticles whose byline prints “Fathia Ehmouda Zaid”